Old drug, new hope: repurposed pill targets root of debilitating Women's pain
NCT ID NCT03928288
Summary
This study tested whether adding an existing, non-hormonal drug called cabergoline to standard hormonal therapy could better control the chronic pain of endometriosis. It involved 129 adolescent and adult women with surgically-confirmed endometriosis who were already on hormonal treatment but still had significant pain. Participants were randomly assigned to take either cabergoline or a placebo (sugar pill) twice a week for six months to see if it safely reduced their pain and improved daily life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02115, United States
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Children's Hospital Boston
Boston, Massachusetts, 02115, United States
-
Childrens Hospital Colorado
Aurora, Colorado, 80045, United States
-
Standford University
Palo Alto, California, 94305, United States
-
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.